Seres Therapeutics, Inc.·4

Feb 11, 4:15 PM ET

von Moltke Lisa 4

4 · Seres Therapeutics, Inc. · Filed Feb 11, 2025

Insider Transaction Report

Form 4
Period: 2025-02-07
von Moltke Lisa
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-07+650,000650,000 total
    Exercise: $0.78Exp: 2035-02-06Common Stock (650,000 underlying)
Footnotes (1)
  • [F1]The option will vest as to 25% of the shares on February 7, 2026. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4